Skip to content

LENSAR, Inc. LNSR Financing Cash Flow

Financing Cash Flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$530M-94.9%
Staar Surgical logo
Staar SurgicalSTAA
-$1.69M-78.6%
Bausch + Lomb logo
Bausch + LombBLCO
-$20M-165%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$1.85M-35.5%
Schering-Plough logo
Schering-PloughSGP
$157.76M+215%
IAR
Integra LifeSciencesIART
$8.3M-76.5%

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-53.1%
Enterprise value$65.21M-54.9%
P/E2.4×
P/S1.2×-1.3×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Reported directly by LENSAR, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s financing cash flow?
LENSAR, Inc. (LNSR) reported financing cash flow of -$209K in Q1 2026.
How has LENSAR, Inc.'s financing cash flow changed year-over-year?
LENSAR, Inc.'s financing cash flow decreased by 102.2% year-over-year, from $9.69M to -$209K.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.